| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A multicenter phase II study of TAS-102 monotherapy in patients with pre-treated advanced gastric cancer (EPOC1201)
|
Bando, Hideaki
|
|
2016
|
62 |
C |
p. 46-53
8 p.
|
artikel
|
| 2 |
Can immunostimulatory agents enhance the abscopal effect of radiotherapy?
|
Levy, Antonin
|
|
2016
|
62 |
C |
p. 36-45
10 p.
|
artikel
|
| 3 |
Clinical activity of sunitinib rechallenge in metastatic renal cell carcinoma—Results of the REchallenge with SUnitinib in MEtastatic RCC (RESUME) Study
|
Oudard, Stéphane
|
|
2016
|
62 |
C |
p. 28-35
8 p.
|
artikel
|
| 4 |
HannaH phase III randomised study: Association of total pathological complete response with event-free survival in HER2-positive early breast cancer treated with neoadjuvant–adjuvant trastuzumab after 2 years of treatment-free follow-up
|
Jackisch, Christian
|
|
2016
|
62 |
C |
p. 62-75
14 p.
|
artikel
|
| 5 |
Implementation of mechanism of action biology-driven early drug development for children with cancer
|
Pearson, Andrew D.J.
|
|
2016
|
62 |
C |
p. 124-131
8 p.
|
artikel
|
| 6 |
Individual patient information to select patients for different radiation techniques
|
Quik, E.H.
|
|
2016
|
62 |
C |
p. 18-27
10 p.
|
artikel
|
| 7 |
Innovative radiotherapy of sarcoma: Proton beam radiation
|
DeLaney, Thomas F.
|
|
2016
|
62 |
C |
p. 112-123
12 p.
|
artikel
|
| 8 |
Nomograms for survival prediction in patients undergoing liver resection for hepatitis B virus related early stage hepatocellular carcinoma
|
Li, Jun
|
|
2016
|
62 |
C |
p. 86-95
10 p.
|
artikel
|
| 9 |
Phase 1 study of dalotuzumab monotherapy and ridaforolimus–dalotuzumab combination therapy in paediatric patients with advanced solid tumours
|
Frappaz, Didier
|
|
2016
|
62 |
C |
p. 9-17
9 p.
|
artikel
|
| 10 |
RECIST 1.1 – Standardisation and disease-specific adaptations: Perspectives from the RECIST Working Group
|
Schwartz, Lawrence H.
|
|
2016
|
62 |
C |
p. 138-145
8 p.
|
artikel
|
| 11 |
RECIST 1.1—Update and clarification: From the RECIST committee
|
Schwartz, Lawrence H.
|
|
2016
|
62 |
C |
p. 132-137
6 p.
|
artikel
|
| 12 |
Resistance to combination BRAF and MEK inhibition in metastatic melanoma: Where to next?
|
Welsh, Sarah J.
|
|
2016
|
62 |
C |
p. 76-85
10 p.
|
artikel
|
| 13 |
Survival of elderly patients with multiple myeloma—Effect of upfront autologous stem cell transplantation
|
Merz, Maximilian
|
|
2016
|
62 |
C |
p. 1-8
8 p.
|
artikel
|
| 14 |
Survival results of a randomised two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of S-1 plus cisplatin (SC) and paclitaxel plus cisplatin (PC) followed by D2 gastrectomy for resectable advanced gastric cancer
|
Yoshikawa, Takaki
|
|
2016
|
62 |
C |
p. 103-111
9 p.
|
artikel
|
| 15 |
Taking stock and looking ahead: Behavioural science lessons for implementing the nonavalent human papillomavirus vaccine
|
Forster, Alice S.
|
|
2016
|
62 |
C |
p. 96-102
7 p.
|
artikel
|
| 16 |
Targeting ALCAM in the cryo-treated tumour microenvironment successfully induces systemic anti-tumour immunity
|
Kudo-Saito, Chie
|
|
2016
|
62 |
C |
p. 54-61
8 p.
|
artikel
|
Tijdschrift beschrijving